Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept

Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept

Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be co...

Full description

Bibliographic Details
Main Authors: Sundeep Chowdhry, Akhilesh Shukla, Paschal D'souza, Tapan Dhali, Prashansa Jaiswal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:International Journal of Mycobacteriology
Subjects:
Biologics
Etanercept
Erythema nodosum leprosum
Leprosy
Treatment
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=2;spage=223;epage=225;aulast=Chowdhry
id doaj-dddacb860a614f2baf4a729c90cbc2cb
record_format Article
spelling doaj-dddacb860a614f2baf4a729c90cbc2cb2020-11-24T21:23:52ZengWolters Kluwer Medknow PublicationsInternational Journal of Mycobacteriology2212-55312212-554X2016-01-015222322510.1016/j.ijmyco.2016.02.002Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor EtanerceptSundeep ChowdhryAkhilesh ShuklaPaschal D'souzaTapan DhaliPrashansa JaiswalErythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=2;spage=223;epage=225;aulast=ChowdhryBiologicsEtanerceptErythema nodosum leprosumLeprosyTreatment
collection DOAJ
language English
format Article
sources DOAJ
author Sundeep Chowdhry
Akhilesh Shukla
Paschal D'souza
Tapan Dhali
Prashansa Jaiswal
spellingShingle Sundeep Chowdhry
Akhilesh Shukla
Paschal D'souza
Tapan Dhali
Prashansa Jaiswal
Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept
International Journal of Mycobacteriology
Biologics
Etanercept
Erythema nodosum leprosum
Leprosy
Treatment
author_facet Sundeep Chowdhry
Akhilesh Shukla
Paschal D'souza
Tapan Dhali
Prashansa Jaiswal
author_sort Sundeep Chowdhry
title Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept
title_short Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept
title_full Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept
title_fullStr Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept
title_full_unstemmed Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept
title_sort treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor etanercept
publisher Wolters Kluwer Medknow Publications
series International Journal of Mycobacteriology
issn 2212-5531
2212-554X
publishDate 2016-01-01
description Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.
topic Biologics
Etanercept
Erythema nodosum leprosum
Leprosy
Treatment
url http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=2;spage=223;epage=225;aulast=Chowdhry
work_keys_str_mv AT sundeepchowdhry treatmentofsevererefractoryerythemanodosumleprosumwithtumornecrosisfactorinhibitoretanercept
AT akhileshshukla treatmentofsevererefractoryerythemanodosumleprosumwithtumornecrosisfactorinhibitoretanercept
AT paschaldsouza treatmentofsevererefractoryerythemanodosumleprosumwithtumornecrosisfactorinhibitoretanercept
AT tapandhali treatmentofsevererefractoryerythemanodosumleprosumwithtumornecrosisfactorinhibitoretanercept
AT prashansajaiswal treatmentofsevererefractoryerythemanodosumleprosumwithtumornecrosisfactorinhibitoretanercept
_version_ 1725990736985325568

Similar Items